Assignee profile:

Hetero Research Foundation

City:

Country:

India

Published Applications:

36

Last publication date:

2018-05-31

Patent Grants:

36

Last grant date:

2019-10-15

Top Inventors for applications by Hetero Research Foundation

These are the the leading inventors for applications assigned to Hetero Research Foundation:

Recent patent applications by Hetero Research Foundation

Hetero Research Foundation based in , IN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-05-31 ✅ Patent 10,442,769 granted on 2019-10-15
US20180148412A1
Chemistry; metallurgy

Process for the preparation of intermediate of dolutegravir

#2 | 2017-11-23 ✅ Patent 9,963,430 granted on 2018-05-08
US20170334858A1
Chemistry; metallurgy

Process for the preparation of intermediate of dolutegravir

#3 | 2017-02-02 ✅ Patent 9,815,806 granted on 2017-11-14
US20170029392A1
Chemistry; metallurgy

Process for cabazitaxel

#4 | 2016-09-01 ✅ Patent 9,518,020 granted on 2016-12-13
US20160251313A1
Chemistry; metallurgy

Process for Regorafenib

#5 | 2015-10-15 ✅ Patent 9,381,199 granted on 2016-07-05
US20150290199A1
Human necessities

Linagliptin solid dispersion

#6 | 2015-09-10 ✅ Patent 9,783,542 granted on 2017-10-10
US20150252045A1
Chemistry; metallurgy

Process for pralatrexate

#7 | 2015-09-03 ✅ Patent 9,345,712 granted on 2016-05-24
US20150246053A1
Human necessities

Solid oral compositions of tolvaptan

#8 | 2015-07-02 ✅ Patent 9,624,207 granted on 2017-04-18
US20150183767A1
Chemistry; metallurgy

Polymorphs of azilsartan medoxomil

#9 | 2015-07-02 ✅ Patent 9,139,535 granted on 2015-09-22
US20150183751A1
Chemistry; metallurgy

Process for rilpivirine using novel intermediate

#10 | 2015-07-02 ✅ Patent 10,206,874 granted on 2019-02-19
US20150182458A1
Human necessities

Rufinamide solid dispersion

#11 | 2015-05-14 ✅ Patent 9,156,789 granted on 2015-10-13
US20150133670A1
Chemistry; metallurgy

Process for sorafenib tosylate polymorph III

#12 | 2015-03-19 ✅ Patent 9,175,005 granted on 2015-11-03
US20150080589A1
Chemistry; metallurgy

Crystalline hydrochloride salt of darunavir

#13 | 2014-11-27 ✅ Patent 9,233,935 granted on 2016-01-12
US20140350038A1
Chemistry; metallurgy

Rilpivirine hydrochloride

#14 | 2014-08-21 ✅ Patent 9,115,118 granted on 2015-08-25
US20140235859A1
Chemistry; metallurgy

Process for the resolution of omeprazole

#15 | 2014-08-14 ✅ Patent 9,126,949 granted on 2015-09-08
US20140228385A1
Chemistry; metallurgy

Process for rilpivirine

#16 | 2014-07-17 ✅ Patent 9,580,440 granted on 2017-02-28
US20140200356A1
Chemistry; metallurgy

Polymorphs of darunavir

#17 | 2014-05-01 ✅ Patent 9,273,010 granted on 2016-03-01
US20140121384A1
Chemistry; metallurgy

Process for bendamustine hydrochloride

#18 | 2014-04-10 ✅ Patent 9,096,556 granted on 2015-08-04
US20140100252A1
Chemistry; metallurgy

Amorphous ritonavir co-precipitated

#19 | 2013-10-17 ✅ Patent 9,132,132 granted on 2015-09-15
US20130274262A1
Human necessities

Pharmaceutical compositions of linezolid

#20 | 2013-09-19 ✅ Patent 9,150,547 granted on 2015-10-06
US20130245262A1
Chemistry; metallurgy

Process for the preparation of pazopanib using novel intermediate

#21 | 2013-08-15 ✅ Patent 8,779,143 granted on 2014-07-15
US20130211091A1
Chemistry; metallurgy

Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form

#22 | 2013-07-25 ✅ Patent 9,024,015 granted on 2015-05-05
US20130190490A1
Chemistry; metallurgy

Process for preparing tolvaptan intermediates

#23 | 2013-05-30 ✅ Patent 8,962,833 granted on 2015-02-24
US20130137868A1
Chemistry; metallurgy

Salts of raltegravir

#24 | 2013-04-18 ✅ Patent 8,598,341 granted on 2013-12-03
US20130096148A1
Chemistry; metallurgy

Process for etravirine intermediate and polymorphs of etravirine

#25 | 2013-03-21 ✅ Patent 8,853,430 granted on 2014-10-07
US20130072552A1
Chemistry; metallurgy

Crystalline hydrochloride salt of darunavir

#26 | 2012-09-13 ✅ Patent 8,383,811 granted on 2013-02-26
US20120232069A1
Chemistry; metallurgy

Process for preparing efavirenz polymorph

#27 | 2012-09-06 ✅ Patent 9,138,412 granted on 2015-09-22
US20120225121A1
Human necessities

Bioequivalent formulation of efavirenz

#28 | 2012-08-23 ✅ Patent 8,748,619 granted on 2014-06-10
US20120215003A1
Chemistry; metallurgy

Process for the resolution of omeprazole

#29 | 2012-08-02 ✅ Patent 8,420,822 granted on 2013-04-16
US20120197021A1
Chemistry; metallurgy

Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles

#30 | 2012-07-12 ✅ Patent 8,742,105 granted on 2014-06-03
US20120178930A1
Chemistry; metallurgy

Polymorphs of raltegravir potassium

#31 | 2012-03-29 ✅ Patent 8,481,554 granted on 2013-07-09
US20120077772A1
Human necessities

Solid oral dosage forms of lamivudine

#32 | 2012-01-19 ✅ Patent 8,552,036 granted on 2013-10-08
US20120015987A1
Chemistry; metallurgy

Polymorph of atazanavir sulfate

#33 | 2011-12-15 ✅ Patent 8,329,740 granted on 2012-12-11
US20110306647A1
Chemistry; metallurgy

Polymorphs of sunitinib malate

#34 | 2011-12-01 ✅ Patent 8,445,506 granted on 2013-05-21
US20110294839A1
Chemistry; metallurgy

Polymorphs of lopinavir

#35 | 2011-09-29 ✅ Patent 8,492,577 granted on 2013-07-23
US20110237822A1
Chemistry; metallurgy

Process for preparation of valsartan intermediate

#36 | 2011-06-09 ✅ Patent 8,536,151 granted on 2013-09-17
US20110137034A1
Chemistry; metallurgy

Process for preparing lamivudine polymorph form

AssigneeID:

459635 ⎘